Belgium· BE-AMP-SAM508613-00
Berberis-Homaccord
A medicinal product containing berberis vulgaris, registered in Belgium by Heel Belgium.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Berberis vulgaris
- Manufacturer
- Heel Belgium
- Country
- Belgium (BE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
- be_apb0459370
- be_apb0457739
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Berberis vulgaris in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/13545b4b-ab0a-486d-9b80-c289a924e39c GET /v1/drugs/13545b4b-ab0a-486d-9b80-c289a924e39c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Oral drops, solution",
"source": "afmps",
"status": "REVOKED",
"name_en": "Berberis-Homaccord",
"name_fr": "Berberis-Homaccord",
"name_nl": "Berberis-Homaccord",
"amp_code": "SAM508613-00",
"strengths": null,
"pack_count": 2,
"substances": [
"Berberis vulgaris",
"Veratrum album",
"Citrullus colocynthis"
],
"medicine_type": "HOMEOPATHIC",
"atc_description": null,
"authorisation_numbers": [
"HO-BE508613"
]
}See everything about berberis vulgaris.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.